Contact
Please use this form to send email to PR contact of this press release:
Histogen Announces Completion of Final Dosing Timepoint Milestone in its 1b/2a Trial for Androgenic Alopecia in Men
TO:
Please use this form to send email to PR contact of this press release:
Histogen Announces Completion of Final Dosing Timepoint Milestone in its 1b/2a Trial for Androgenic Alopecia in Men
TO: